Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 27, 2003
A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancyAdrienne Einarson, Lori Bonari, Sharon Voyer-Lavigne, et al.
MCN. the American Journal of Maternal Child Nursing|July 31, 2008
Addressing concerns of pregnant and lactating women after the 2005 hurricanes: the OTIS responseDorothy Quinn, Sharon Voyer Lavigne, Christina Chambers, et al.
American Journal of Obstetrics and Gynecology|March 5, 2005
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative studyBrian Chun-Fai-Chan, Gideon Koren, Ibrahim Fayez, et al.
The Journal of Clinical Psychiatry|September 13, 2006
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomesJosephine Djulus, Gideon Koren, Thomas R Einarson, et al.
European Journal of Clinical Pharmacology|August 27, 2009
Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomesMoumita Sarkar, Gideon Koren, Sanjog Kalra, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 18, 2005
A survey of pregnant women using isotretinoinJulia Robertson, Janine E Polifka, Marina Avner, et al.
Archives of Women'S Mental Health|March 10, 2016
Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Psychological Assessment|May 5, 2015
The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Research in Nursing & Health|April 19, 2012
Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants studyFatiha Karam, Anick Bérard, Odile Sheehy, et al.
Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.
Pageof 1